Carregant...
Endocrine therapy resistance: new insights
The estrogen receptor positive (ER+) subset is the dominant contributor to global deaths from breast cancer which now exceeds 500,000 deaths annually. Lethality is driven by endocrine resistance, which has been shown to be associated with high mutational rates and extreme subclonal diversity. Treatm...
Guardat en:
| Publicat a: | Breast |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6939855/ https://ncbi.nlm.nih.gov/pubmed/31839155 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S0960-9776(19)31118-X |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|